|Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure|
M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ...
Circulation 131 (1), 54-61, 2015
|Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the …|
T Barbui, G Barosi, A Grossi, L Gugliotta, LN Liberato, M Marchetti, ...
haematologica 89 (2), 215-232, 2004
|Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study|
A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ...
European journal of clinical pharmacology 67, 507-519, 2011
|Outcomes of patients hospitalized with community-acquired, health care–associated, and hospital-acquired pneumonia|
M Venditti, M Falcone, S Corrao, G Licata, P Serra, ...
Annals of internal medicine 150 (1), 19-26, 2009
|Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI With ACEI to determine …|
SL Kristensen, D Preiss, PS Jhund, I Squire, JS Cardoso, B Merkely, ...
Circulation: Heart Failure 9 (1), e002560, 2016
|The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia|
G Barosi, A Ambrosetti, C Finelli, A Grossi, P Leoni, NL Liberato, MC Petti, ...
British journal of haematology 104 (4), 730-737, 1999
|Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]|
M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, ...
|Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study|
A Nobili, A Marengoni, M Tettamanti, F Salerno, L Pasina, C Franchi, ...
European journal of internal medicine 22 (6), 597-602, 2011
|Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2–positive breast cancer|
NL Liberato, M Marchetti, G Barosi
Journal of Clinical Oncology 25 (6), 625-633, 2007
|Multimorbidity and polypharmacy in the elderly: lessons from REPOSI|
PM Mannucci, A Nobili, REPOSI Investigators
Internal and emergency medicine 9, 723-734, 2014
|A prognostic classification of myelofibrosis with myeloid metaplasia|
G Barosi, C Berzuini, LN Liberato, A Costa, G Polino, E Ascari
British journal of haematology 70 (4), 397-401, 1988
|Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly|
L Pasina, A Nobili, M Tettamanti, F Salerno, S Corrao, A Marengoni, ...
European journal of internal medicine 22 (2), 205-210, 2011
|Risk factors for hospital readmission of elderly patients|
C Franchi, A Nobili, D Mari, M Tettamanti, CD Djade, L Pasina, F Salerno, ...
European journal of internal medicine 24 (1), 45-51, 2013
|Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia|
G Barosi, M Marchetti, NL Liberato
British journal of cancer 78 (6), 781-787, 1998
|Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study|
S Corrao, P Santalucia, C Argano, CD Djade, E Barone, M Tettamanti, ...
European journal of internal medicine 25 (7), 617-623, 2014
|Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.|
G Barosi, A Ambrosetti, A Buratti, C Finelli, NL Liberato, S Quaglini, ...
Leukemia 7 (2), 200-206, 1993
|Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study|
L Pasina, CD Djade, M Tettamanti, C Franchi, F Salerno, S Corrao, ...
Journal of clinical pharmacy and therapeutics 39 (5), 511-515, 2014
|Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)|
G Barosi, D Bordessoule, J Briere, F Cervantes, JL Demory, B Dupriez, ...
Blood 106 (8), 2849-2853, 2005
|Drug–drug interactions in a cohort of hospitalized elderly patients|
L Pasina, CD Djade, A Nobili, M Tettamanti, C Franchi, F Salerno, ...
pharmacoepidemiology and drug safety 22 (10), 1054-1060, 2013
|Mortality rate and risk factors for gastrointestinal bleeding in elderly patients|
MV Lenti, L Pasina, S Cococcia, L Cortesi, E Miceli, CC Dominioni, ...
European Journal of Internal Medicine 61, 54-61, 2019